Personalis Inc (PSNL)
Healthcare
Diagnostics & Research
13.50 $
+2.4%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures as a percentage of total assets in the same period.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 64.6% | 65.4% | 65.2% | 61.7% | 61.0% | 71.0% | 75.1% | 75.5% | 74.7% | 71.8% | 80.2% | 79.3% | |
| 39.0% | 31.9% | 25.3% | 22.5% | 25.7% | 31.6% | 33.8% | 26.0% | 20.6% | 20.6% | 37.2% | 22.6% | |
| 55.1% | 53.2% | 50.7% | 48.9% | 46.9% | 59.9% | 68.5% | 67.9% | 67.0% | 62.0% | 71.8% | 71.7% | |
| 4.1% | 6.0% | 7.9% | 5.8% | 7.0% | 5.6% | 3.0% | 4.0% | 3.8% | 5.9% | 4.8% | 4.0% | |
| 1.9% | 3.6% | 2.5% | 2.5% | 2.5% | 2.6% | 1.5% | 1.5% | 1.8% | 1.5% | 1.8% | 2.1% | |
| 23.9% | 33.1% | – | – | – | – | – | – | – | – | – | – | |
| 29.3% | 33.3% | 42.5% | 38.2% | 39.5% | 30.5% | 24.9% | 24.1% | 26.2% | 29.4% | 21.8% | 21.7% | |
| 11.5% | 14.3% | 21.0% | 16.1% | 18.4% | 15.2% | 11.5% | 10.9% | 12.3% | 14.9% | 11.9% | 12.0% | |
| 3.2% | 1.6% | 4.2% | 4.8% | 5.1% | 3.8% | 3.5% | 3.8% | 3.5% | 3.4% | 2.4% | 2.4% | |
| 3.6% | 4.0% | 6.6% | 4.7% | 5.4% | 5.2% | 2.4% | 2.9% | 3.8% | 4.6% | 3.9% | 3.9% | |
| 0.2% | – | – | – | 0.4% | 0.2% | – | – | – | – | – | – | |
| 70.7% | 66.7% | 57.5% | 61.8% | 60.5% | 69.5% | 75.1% | 75.9% | 73.8% | 70.6% | 78.2% | 78.3% | |
| -165.8% | -195.1% | -208.2% | -246.7% | -266.6% | -222.4% | -203.5% | -207.0% | -226.5% | -250.1% | -188.9% | -203.2% | |
| 19.1% | 21.5% | 22.0% | 26.0% | 28.2% | 25.5% | 27.0% | 32.0% | 34.2% | 36.5% | 27.6% | 32.0% |
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.